These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29292969)

  • 1. [Unfortunate decision on hepatitis B vaccination].
    Hagstam P; Gröön P
    Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292969
    [No Abstract]   [Full Text] [Related]  

  • 2. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh.
    Bhatia V; Swami HM
    Indian J Med Sci; 2000 Aug; 54(8):347-9. PubMed ID: 11143750
    [No Abstract]   [Full Text] [Related]  

  • 6. Universal hepatitis B vaccination.
    Piazza M
    Lancet Infect Dis; 2008 Feb; 8(2):88-9; author reply 90. PubMed ID: 18222158
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive vaccination of adolescents: is consent by parents always necessary?].
    Nassauer KA
    Fortschr Med; 1997 Apr; 115(10):34, 37-8. PubMed ID: 9206684
    [No Abstract]   [Full Text] [Related]  

  • 9. [Introduction of general hepatitis B vaccination in Switzerland].
    Zimmermann H; Vaudaux B; Kammerlander R
    Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developed countries could pay for hepatitis B vaccination in developing countries.
    Gay NJ; Edmunds WJ
    BMJ; 1998 May; 316(7142):1457. PubMed ID: 9572767
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of Japan's hepatitis vaccine policy to national Hepatitis B prevention and control.
    Takahashi K; Kobayashi J; Sugiura Y
    J Public Health Policy; 2012 Feb; 33(1):136-8. PubMed ID: 22282169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 15. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
    Puliyel JM
    Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
    [No Abstract]   [Full Text] [Related]  

  • 16. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Viral Hepatitis Prevention Board and earlier efforts at hepatitis B control.
    Wilde H
    Vaccine; 1996 Jun; 14(8):837-8. PubMed ID: 8817832
    [No Abstract]   [Full Text] [Related]  

  • 18. Disparities in hepatitis B vaccine funding in Australian jurisdictions: limiting access for priority populations.
    MacLachlan JH; Allard NL; Cowie BC
    Aust N Z J Public Health; 2015 Apr; 39(2):192. PubMed ID: 25827189
    [No Abstract]   [Full Text] [Related]  

  • 19. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 20. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.